SELLAS Life Sciences Group, Inc. Amortization of Intangible Assets
SELLAS Life Sciences Group, Inc. (SLS) reported Amortization of Intangible Assets of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2019-03-22
- SELLAS Life Sciences Group, Inc. amortization of intangible assets for the quarter ending 2015-06-30 was $442.00K, a 351.02% increase year-over-year.
- SELLAS Life Sciences Group, Inc. amortization of intangible assets for the quarter ending 2015-03-31 was $146.00K, a 60.44% increase year-over-year.
- SELLAS Life Sciences Group, Inc. amortization of intangible assets for the quarter ending 2014-12-31 was $181.00K, a 105.68% increase year-over-year.
- SELLAS Life Sciences Group, Inc. amortization of intangible assets for the quarter ending 2014-09-30 was $70.00K, a 62.79% increase year-over-year.
- SELLAS Life Sciences Group, Inc. amortization of intangible assets for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- SELLAS Life Sciences Group, Inc. amortization of intangible assets for fiscal 2017 was $1.88M.
- SELLAS Life Sciences Group, Inc. amortization of intangible assets for fiscal 2014 was $440.00K, a 235.88% increase from fiscal 2013.
- SELLAS Life Sciences Group, Inc. amortization of intangible assets for fiscal 2013 was $131.00K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-22 | ||||
| 2017-12-31 | $1.88M 10-K · filed 2019-03-22 | ||||
| 2015-06-30 | $442.00K 10-Q · filed 2015-08-06 | $588.00K 10-Q · filed 2015-08-06 | $769.00K derived: sum of 3 quarters · filed 2015-08-06 | $839.00K derived: sum of 4 quarters · filed 2015-08-06 | |
| 2015-03-31 | $146.00K 10-Q · filed 2015-05-07 | $327.00K derived: sum of 2 quarters · filed 2015-05-07 | $397.00K derived: sum of 3 quarters · filed 2015-05-07 | $495.00K derived: sum of 4 quarters · filed 2015-08-06 | |
| 2014-12-31 | $181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-05 | $251.00K derived: sum of 2 quarters · filed 2015-03-05 | $349.00K derived: sum of 3 quarters · filed 2015-08-06 | $440.00K 10-K · filed 2015-03-05 | |
| 2014-09-30 | $70.00K 10-Q · filed 2014-11-05 | $168.00K derived: sum of 2 quarters · filed 2015-08-06 | $259.00K 10-Q · filed 2014-11-05 | $347.00K derived: sum of 4 quarters · filed 2015-08-06 | |
| 2014-06-30 | $98.00K 10-Q · filed 2015-08-06 | $189.00K 10-Q · filed 2015-08-06 | $277.00K derived: sum of 3 quarters · filed 2015-08-06 | $320.00K derived: sum of 4 quarters · filed 2015-08-06 | |
| 2014-03-31 | $91.00K 10-Q · filed 2015-05-07 | $179.00K derived: sum of 2 quarters · filed 2015-05-07 | $222.00K derived: sum of 3 quarters · filed 2015-05-07 | $222.00K derived: sum of 4 quarters · filed 2015-05-07 | |
| 2013-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-05 | $131.00K derived: sum of 2 quarters · filed 2015-03-05 | $131.00K derived: sum of 3 quarters · filed 2015-03-05 | $131.00K 10-K · filed 2015-03-05 | |
| 2013-09-30 | $43.00K 10-Q · filed 2014-11-05 | $43.00 10-Q · filed 2013-11-06 | $43.00K derived: sum of 2 quarters · filed 2014-11-05 | $43.00K 10-Q · filed 2014-11-05 | |
| 2013-06-30 | $0.00 10-Q · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |